Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan.

Background: The prevalence of antithyroid drug (ATD)-related drug-induced liver injury (DILI) has been reported to vary among patients in several countries. The purpose of this study was to summarize the prevalence of liver injury induced by ATD and to determine the actual prevalence of severe liver injury. Methods: The medical records of 18,558 patients who were newly diagnosed with Graves' disease between January 2005 and December 2016 were retrospectively reviewed. Severe DILI was defined as alanine aminotransferase (ALT) 8 times higher than the upper limit of normal (ULN) or total bilirubin (T-bil) 3 times higher than the ULN. The most severe DILI was defined as ALT higher than 20 times the ULN or T-bil higher than 10 times the ULN. Results: A total of 461 subjects (470 cases) were analyzed, and they consisted of 10 males and 451 females, with a median age of 37 years (range 10-82 years). Nine of 461 patients had severe DILI with both drugs. The total prevalence of severe DILI in this study was 2.5%, and the prevalence of DILI by drug was 1.4% with metimazole (MMI) (n = 198) and 6.3% with propylthiouracil (PTU) (n = 272) (p < 0.001). The prevalence of the most severe ATD-related DILI was 0.22% (n = 40), and the prevalence for each drug was 0.08% with MMI (n = 11) and 0.68% with PTU (n = 29). The median time to DILI development was 30 days (range 7-314 days), and all patients recovered from DILI, with no fatalities. The prevalence of MMI-related DILI was significantly age dependent (p < 0.001). Conclusions: Though there were no fatalities in this study, the prevalence of PTU-related severe DILI was significantly higher than that of MMI-related severe DILI.

[1]  Jun Zhang,et al.  Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China. , 2015, Thyroid : official journal of the American Thyroid Association.

[2]  J. Kung,et al.  Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity , 2014, Expert opinion on drug safety.

[3]  C. Hsieh,et al.  Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study. , 2014, British journal of clinical pharmacology.

[4]  ItoKoichi,et al.  Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment. , 2014 .

[5]  S. Nishikawa,et al.  Th2 cytokine‐mediated methimazole‐induced acute liver injury in mice , 2012, Journal of applied toxicology : JAT.

[6]  M. Kami,et al.  Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease. , 2012, The Journal of clinical endocrinology and metabolism.

[7]  S. Rivkees,et al.  Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. , 2010, The Journal of clinical endocrinology and metabolism.

[8]  Kunihiko Ito,et al.  Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. , 2009, The Journal of clinical endocrinology and metabolism.

[9]  S. Rivkees,et al.  Putting propylthiouracil in perspective. , 2009, The Journal of clinical endocrinology and metabolism.

[10]  K. Tajiri,et al.  Practical guidelines for diagnosis and early management of drug-induced liver injury. , 2008, World journal of gastroenterology.

[11]  A. Miyauchi,et al.  Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis. , 2008, Thyroid : official journal of the American Thyroid Association.

[12]  Ashok Kumar,et al.  Hyperthyroidism induces apoptosis in rat liver through activation of death receptor-mediated pathways. , 2007, Journal of hepatology.

[13]  J. Castell,et al.  Allergic hepatitis induced by drugs , 2006, Current opinion in allergy and clinical immunology.

[14]  P. Watkins,et al.  Liver transplantation for acute liver failure from drug induced liver injury in the United States , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  Ashok Kumar,et al.  Severe hyperthyroidism induces mitochondria‐mediated apoptosis in rat liver , 2004, Hepatology.

[16]  J. Ruiz,et al.  Fulminant Hepatic Failure Associated with Propylthiouracil , 2003, The Annals of pharmacotherapy.

[17]  S. Dong,et al.  The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study , 2001, American Journal of Gastroenterology.

[18]  H. Pantazi,et al.  Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. , 2000, The Journal of clinical endocrinology and metabolism.

[19]  J. Reyes,et al.  Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? , 1997, The Journal of clinical endocrinology and metabolism.

[20]  Y. Liaw,et al.  Clinical associations between thyroid and liver diseases , 1995, Journal of gastroenterology and hepatology.

[21]  Y. Liaw,et al.  Hepatic Injury during Propylthiouracil Therapy in Patients with Hyperthyroidism: A Cohort Study , 1993, Annals of Internal Medicine.

[22]  R. A. Neal,et al.  Inhibition of hepatic mixed-function oxidase activity in vitro and in vivo by various thiono-sulfur-containing compounds. , 1975, Biochemical pharmacology.